RONIT SHABTIAN: Open Payments
NPI 1336431576 · GREAT NECK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 21 payments from 8 companies in 2025. Trend: 2023 $1,516 · 2024 $237 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 6 | $202 |
| REVANCE THERAPEUTICS, INC. | 1 | $145 |
| Incyte Corporation | 4 | $96 |
| Organon LLC | 3 | $70 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: SOFDRA, DAXXIFY, OPZELURA, VALCHLOR, VTAMA, RINVOQ, LIBTAYO, SKYRIZI.
Industry payments across NY — which companies pay providers there.
